509Polisecki E, Muallem H, Maeda N, et al.; on behalf of the Prospective Study of Pravastatin in the
Elderly at Risk (PROSPER) Investigators. Genetic variation at the LDL receptor and HMG-
CoA reductase gene loci, lipid levels, statin response, and cardiovascular disease incidence in
PROSPER. Atherosclerosis 2008;200:109–14.
Qi L, Parast L, Cai T, et al. Genetic susceptibility to coronary heart disease in type 2 diabetes: 3
independent studies. J Am Coll Cardiol. 2011;58:2675–82.
Rosencher N, Albaladejo P. A new approach with anticoagulant development: tailoring anticoagu-
lant therapy with dabigatran etexilate according to patient risk. Expert Opin Pharmacoth.
2012;13:217–26.
Saracini C, Vestrini A, Galora S, et al. Pharmacogenetics of clopidogrel: comparison between a
standard and a rapid genetic testing. Genet Test Mol Biomark. 2012;16:500–3.
Shiffman D, Chasman DI, Zee RY, et al. A kinesin family member 6 variant is associated with
coronary heart disease in the Women’s Health Study. J Am Coll Cardiol. 2008;51:444–8.
Siest G, Marteau JB, Maumus S, et al. Pharmacogenomics and pharmacoproteomics: a strategy for
cardio-vascular drugs. Ann Pharm Fr. 2007;65:203–10.
Sussman J, Vijan S, Hayward R. Using benefi t-based tailored treatment to improve the use of
antihypertensive medications. Circulation. 2013;128:2309–17.
Taylor AL, Ziesche S, Yancy C, et al. Combination of isosorbide dinitrate and hydralazine in
blacks with heart failure. N Engl J Med. 2004;351:2049–57.
Teekakirikul P, Kelly MA, Rehm HL, et al. Inherited cardiomyopathies: molecular genetics and
clinical genetic testing in the postgenomic era. J Mol Diagn. 2013;15:158–70.
Terra SG, Pauly DF, Lee CR, et al. Beta-adrenergic receptor polymorphisms and responses during
titration of metoprolol controlled release/extended release in heart failure. Clin Pharmacol
Ther. 2005;77:127–37.
Verhoef TI, Ragia G, de Boer A, et al. A randomized trial of genotype-guided dosing of acenocou-
marol and phenprocoumon. N Engl J Med. 2013;369:2304–12.
Vimaleswaran KS, Cavadino A, Berry DJ, LifeLines Cohort Study Investigators, et al. Association
of vitamin D status with arterial blood pressure and hypertension risk: a mendelian randomisa-
tion study. Lancet Diabetes Endocrinol. 2014;2:719–29.
Voora D, Shah SH, Reed CR, et al. Pharmacogenetic predictors of statin-mediated low-density
lipoprotein cholesterol reduction and dose response. Circ Cardiovasc Genet. 2008;1:100–6.
Zhao FL, Zhang YZ, Tai GX, et al. Serum parathyroid hormone as a potential novel biomarker of
coronary heart disease. Genet Test Mol Biomarkers. 2014;18:670–4.
References